HomeTOP STORIESXeris Biopharma raises revenue guidance for 2025 to $260M-$275M amid strong Recorlev... Xeris Biopharma raises revenue guidance for 2025 to $260M-$275M amid strong Recorlev growth By rogerjudd May 8, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleFerroglobe plc outlines trade measures and anticipates $100M-$170M adjusted EBITDA for 2025Next articleWatch: From white smoke to balcony speech, how the new pontiff was unveiled latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
